Literature DB >> 23305742

Clinical, neurological, and electrophysiological features of nodding syndrome in Kitgum, Uganda: an observational case series.

James J Sejvar1, Angelina M Kakooza, Jennifer L Foltz, Issa Makumbi, Anne Deborah Atai-Omoruto, Mugagga Malimbo, Richard Ndyomugyenyi, Lorraine N Alexander, Betty Abang, Robert G Downing, Andrew Ehrenberg, Kristin Guilliams, Sandra Helmers, Paul Melstrom, Dennis Olara, Seth Perlman, Jeffrey Ratto, Edwin Trevathan, Andrea S Winkler, Scott F Dowell, Dkw Lwamafa.   

Abstract

BACKGROUND: Nodding syndrome is an unexplained illness characterised by head-bobbing spells. The clinical and epidemiological features are incompletely described, and the explanation for the nodding and the underlying cause of nodding syndrome are unknown. We aimed to describe the clinical and neurological diagnostic features of this illness.
METHODS: In December, 2009, we did a multifaceted investigation to assess epidemiological and clinical illness features in 13 parishes in Kitgum District, Uganda. We defined a case as a previously healthy child aged 5-15 years with reported nodding and at least one other neurological deficit. Children from a systematic sample of a case-control investigation were enrolled in a clinical case series which included history, physical assessment, and neurological examinations; a subset had electroencephalography (EEG), electromyography, brain MRI, CSF analysis, or a combination of these analyses. We reassessed the available children 8 months later.
FINDINGS: We enrolled 23 children (median age 12 years, range 7-15 years) in the case-series investigation, all of whom reported at least daily head nodding. 14 children had reported seizures. Seven (30%) children had gross cognitive impairment, and children with nodding did worse on cognitive tasks than did age-matched controls, with significantly lower scores on tests of short-term recall and attention, semantic fluency and fund of knowledge, and motor praxis. We obtained CSF samples from 16 children, all of which had normal glucose and protein concentrations. EEG of 12 children with nodding syndrome showed disorganised, slow background (n=10), and interictal generalised 2·5-3·0 Hz spike and slow waves (n=10). Two children had nodding episodes during EEG, which showed generalised electrodecrement and paraspinal electromyography dropout consistent with atonic seizures. MRI in four of five children showed generalised cerebral and cerebellar atrophy. Reassessment of 12 children found that six worsened in their clinical condition between the first evaluation and the follow-up evaluation interval, as indicated by more frequent head nodding or seizure episodes, and none had cessation or decrease in frequency of these episodes.
INTERPRETATION: Nodding syndrome is an epidemic epilepsy associated with encephalopathy, with head nodding caused by atonic seizures. The natural history, cause, and management of the disorder remain to be determined. FUNDING: Division of Global Disease Detection and Emergency Response, US Centers for Disease Control and Prevention.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23305742     DOI: 10.1016/S1474-4422(12)70321-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  65 in total

1.  The challenges of managing children with epilepsy in Africa.

Authors:  Jo M Wilmshurst; Angelina Kakooza-Mwesige; Charles R Newton
Journal:  Semin Pediatr Neurol       Date:  2014-01-14       Impact factor: 1.636

2.  Nodding syndrome, western Uganda, 1994.

Authors:  Christoph Kaiser; Tom Rubaale; Ephraim Tukesiga; Walter Kipp; George Asaba
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

3.  Molecular Mimicry may Underlie a Worm-Associated Epilepsy Syndrome.

Authors:  Kyle A Lyman; Dane M Chetkovich
Journal:  Epilepsy Curr       Date:  2018 May-Jun       Impact factor: 7.500

Review 4.  Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa.

Authors:  Awa Ba-Diop; Benoît Marin; Michel Druet-Cabanac; Edgard B Ngoungou; Charles R Newton; Pierre-Marie Preux
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

5.  New evidence for nodding disease as an autoimmune reaction to Onchocerca volvulus.

Authors:  Michael J Boivin
Journal:  Ann Transl Med       Date:  2017-12

6.  River blindness goes beyond the eye: autoimmune antibodies, cross-reactive with Onchocerca volvulus antigen, detected in brain of patients with Nodding syndrome.

Authors:  Christoph Kaiser; Sébastien D S Pion
Journal:  Ann Transl Med       Date:  2017-12

7.  Unravelling the mysterious onchocerciasis-nodding syndrome link: new developments and future challenges.

Authors:  Angelina Kakooza-Mwesige
Journal:  Ann Transl Med       Date:  2017-12

8.  Proposed guidelines for the management of nodding syndrome.

Authors:  R Idro; K A Musubire; B Byamah Mutamba; H Namusoke; J Muron; C Abbo; R Oriyabuzu; J Ssekyewa; C Okot; D Mwaka; P Ssebadduka; I Makumbi; B Opar; J R Aceng; A K Mbonye
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

Review 9.  Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature.

Authors:  S Musisi; D Akena; E Nakimuli-Mpungu; C Abbo; J Okello
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

10.  MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study.

Authors:  A S Winkler; K Friedrich; S Velicheti; J Dharsee; R König; A Nassri; M Meindl; A Kidunda; T H Müller; L Jilek-Aall; W Matuja; T Gotwald; E Schmutzhard
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.